mesalamine has been researched along with Failure to Thrive in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Failure to Thrive: A condition of substandard growth or diminished capacity to maintain normal function.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattar, LN | 1 |
Abraham, BP | 1 |
Malaty, HM | 1 |
Smith, EO | 1 |
Ferry, GD | 1 |
Braegger, CP | 1 |
Torresani, T | 1 |
Murch, SH | 1 |
Savage, MO | 1 |
Walker-Smith, JA | 1 |
MacDonald, TT | 1 |
2 other studies available for mesalamine and Failure to Thrive
Article | Year |
---|---|
Inflammatory bowel disease characteristics in Hispanic children in Texas.
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Black or African American; Body Ma | 2012 |
Urinary growth hormone in growth-impaired children with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Creatinine; Crohn Disease; Enzyme-Link | 1993 |